CLINICAL_TRIALS
trial_result
· 2014-02-12
Clinical Trial Update: Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) [Phase 2]
Summary
A Phase 2 trial evaluating mesalamine for diarrhea-predominant irritable bowel syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-02-12